Discover 1,918 paid clinical trials in Georgia. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Georgia presents extensive opportunities for healthy volunteers looking to participate in paid studies and individuals with specific health conditions alike. Research hubs in major cities like Atlanta, Augusta, and Savannah are actively recruiting participants, providing access to emerging therapies and top-tier medical care.
Filter
1
Filter results
Results: 1,918
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
for
Non-alcoholic Fatty Liver Disease
Location: Quebec, New York NY, Norfolk VA, Morehead City NC,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18 - 70+
Code: NCT07221227
Phase 3, Recruiting
Comprehensive Assistance and Resources for Effective Diabetic Foot Navigation
for
Diabetic Foot Ulcer
Location: Atlanta GA
Sponsor: Emory University
Sex: All
Age: 18+
Code: NCT07223268
Recruiting
An Open-label Dose Escalation and Expansion, Followed by a Phase II Study of Tulmimetostat (DZR123) and JSB462 (Luxdegalutamide) in Patients With Progressive Metastatic Castrate Resistant Prostate Cancer (mCRPC) (TulmiSTAR-01)
for
Progressive Metastatic Castrate Resistant Prostate Cancer
Location: Halifax, Boston MA, Durham NC, Cleveland OH, Atlanta GA,
Sponsor: Novartis Pharmaceuticals
Sex: Male
Age: 18+
Code: NCT07206056
Phase 1, Phase 2, Recruiting
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
for
Non-muscle Invasive Bladder Cancer
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07206225
Phase 1, Recruiting
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
for
Metastatic Castration-Resistant Prostate Cancer
Location: New Haven CT, Myrtle Beach SC, Charlottesville VA,
Sponsor: Kyntra Bio
Sex: Male
Age: 18+
Code: NCT06842498
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
for
Metastatic Castration-resistant Prostate Cancer
Location: Hartford CT, Sherbrooke, New York NY, Montreal,
Sponsor: Amgen
Sex: Male
Age: 18+
Code: NCT07213674
Phase 3, Recruiting
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
for
Transthyretin Amyloid Cardiomyopathy (ATTR CM)
Location: Halifax, Boston MA, New Haven CT, Quebec, Manhasset NY,
Sponsor: Novo Nordisk A/S
Sex: All
Age: 18+
Code: NCT07207811
Phase 3, Recruiting
Spatial-Motor Stroke-Rehab Study
for
Spatial Neglect, Stroke
Location: Atlanta GA
Sponsor: Emory University
Sex: All
Age: 18 - 70+
Code: NCT06053320
Recruiting
A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed With IgG4-related Disease
for
Immunoglobulin G4 Related Disease
Location: Boston MA, Sherbrooke, New York NY, Montreal,
Sponsor: Sanofi
Sex: All
Age: 18+
Code: NCT07190196
Phase 3, Recruiting
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
for
Chronic Obstructive Pulmonary Disease
Location: Boston MA, Flushing NY, East Orange NJ, Philadelphia PA,
Sponsor: Sanofi
Sex: All
Age: 40 - 70+
Code: NCT07190209
Phase 3, Recruiting
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
for
Chronic Obstructive Pulmonary Disease
Location: New Bedford MA, Quebec, Victoriaville, Trois-Rivieres,
Sponsor: Sanofi
Sex: All
Age: 40 - 70+
Code: NCT07190222
Phase 3, Recruiting
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
for
Bladder Cancer, Squamous Cell Carcinoma of the Lung,
Location: New Haven CT, New York NY, Philadelphia PA, Fairfax VA,
Sponsor: EvolveImmune United, Inc
Sex: All
Age: 18+
Code: NCT07217171
Phase 1, Recruiting
Defecation Patterns in Constipated Patients
for
Constipation by Outlet Obstruction
Location: Augusta GA
Sponsor: The California Medical Innovations Institute, Inc.
Sex: All
Age: 21 - 70+
Code: NCT04903470
Recruiting
Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy
for
Ig-E Mediated Food Allergy
Location: Boston MA, Great Neck NY, New York NY, Montreal,
Sponsor: RAPT Therapeutics, Inc.
Sex: All
Age: 12 - 55
Code: NCT07220811
Phase 2, Recruiting
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
for
Acute Migraine
Location: Boston MA, Waltham MA, Waterbury CT, Commack NY,
Sponsor: Kallyope Inc.
Sex: All
Age: 18+
Code: NCT07674654
Phase 3, Recruiting
A Trial to Evaluate the Safety and Tolerability of DV700P-RNA and DV701B1.1-RNA Immunization in Combination With Antiretroviral Analytical Treatment Interruption (ATI) in People Living With HIV for Elicitation of V3-glycan Antibodies
for
HIV
Location: Boston MA, Atlanta GA, Birmingham AL, Seattle WA
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)